Tumor-associated macrophage (TAM) heterogeneity significantly influences the tumor microenvironment, positioning TAM inhibition as a promising anticancer strategy.
Although several TAM subsets have been described, their functional roles remain unclear.
In this study, we identified a distinct subset of CD9
